▼ SELL
10b5-1 Plan
$ Value
$9K
Shares
373
Price
$25
Filed
Oct 3
Insider
Name
Bellon Christine
Title
Chief Legal Officer
CIK
0001963878
Roles
Officer
Transaction Details
Transaction Date
2025-10-01
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
116,921
Footnotes
These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. 2019 Equity Incentive Plan on September 30, 2021. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2023.
Filing Info
Bellon Christine's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | BEAM | ▼ | $146K |
| 2026-03-31 | BEAM | A | $0 |
| 2026-01-31 | BEAM | A | $0 |
| 2026-01-22 | BEAM | ▼ | $47K |
| 2026-01-15 | BEAM | ▼ | $71K |
| 2026-01-15 | BEAM | ▼ | $554K |
| 2026-01-15 | BEAM | ▼ | $20K |
| 2025-12-31 | BEAM | ▼ | $34K |
| 2025-10-01 | BEAM | ▼ | $9K |
Other Insiders at BEAM (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Evans John M.
CEO
|
— | $3.3M | 2026-04-01 |
|
Ciaramella Giuseppe
President
|
— | $290K | 2026-04-01 |
|
Emany Sravan Kumar
Chief Financial Officer
|
— | — | 2026-03-31 |
|
Bellon Christine
Chief Legal Officer
|
— | $193K | 2026-04-01 |
|
Simon Amy
Chief Medical Officer
|
— | $165K | 2026-04-01 |
|
Cavanagh Bethany J
SVP, Finance and Treasurer
|
— | $297K | 2026-04-01 |